Company: FFWM
Filing Date: 2025-11-03
Form Type: SCHEDULE 13D
Source: 0001999371-25-016764
Chunk: 0

Company: First Foundation Inc.
Filing Date: 2025-11-03
Form: SCHEDULE 13D
Chunk 0
---
 2024, Sam Edelson, who is not an employee of CCA or the Accounts, was appointed to the Board of the Issuer. The foregoing summary of the Investment Agreement is qualified in its entirety by the full text of the Investment Agreement, a copy of which is filed as Exhibit 10.2 in the Issuer's Form 8-K filed with the SEC on July 2, 2024, and is incorporated herein by reference. A copy of the Investment Agreement is filed as Exhibit 2 hereto.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
 On July 8, 2024, pursuant to the Investment Agreement, the Accounts purchased (i) 3,206,392 shares of Common Stock at a price of $4.10 per share, (ii) 3,050 shares of the Issuer's Series A Noncumulative Convertible Preferred Stock (the "Series A Preferred Stock") at the price of $4,100 per share, and (iii) 4,946 shares of the Issuer's Series B noncumulative convertible preferred stock (the "Series B Preferred Stock") at a purchase price of $4,100 per Share. The aggregate purchase price was approximately $46 million. In addition, the Accounts were also issued warrants (the "Series C Warrants") to purchase 4,480 shares of non-voting Series C Preferred Stock, par value $0.001 per share (the "Series C Preferred Stock"), at a price of $5,125 per share, subject to adjustment, which expire on July 8, 2031. Each share of Series C Preferred Stock will convert into 1,000 shares of Common Stock upon a Reg Y Transfer in accordance with the terms of the warrant agreement entered into between the Issuer and the Accounts. These purchases were completed in connection with the Issuer's July 2024 capital raise.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
 Also on July 8, 2024, the Issuer and the Accounts entered into a Registration Rights Agreement (the "RRA"), pursuant to which the Issuer provides customary registration rights to the Accounts, their affiliates and certain permitted transferees with respect to, among other things, (a) the shares of Common Stock purchased under the Investment Agreements, (b) shares of Common Stock issued upon the conversion of shares of the preferred stock purchased under the Investment Agreements or issued upon the exercise of the Warrants and (c) if the Requisite Stockholder Vote